Ciwon sankarar lymphoblastic mai tsanani (B-ALL)

Wata majiyyaciya 'yar shekara 61 daga Siriya da ke fama da cutar sankarar jini mai tsanani (ALL) ta sami sabuwar dama ta rayuwa ta hanyar maganin CAR-T, tare da haɗin gwiwar BIOOCUS, wanda ya samar da samfurin CAR-T da ake amfani da shi wajen maganinta.

Mohammed, ɗan majiyyacin, ya raba doguwar tafiyar mahaifiyarsa da cutar sankarar jini. Bayan an gano yana da cutar a ALL a shekarar 2012, mahaifiyarsa ta fara samun maganin chemotherapy kuma ta warke na tsawon shekaru biyar. Abin takaici, cutar ta sake dawowa a shekarar 2018, wanda ya haifar da wani zagaye na chemotherapy da kuma dashen ƙashi na allogeneic. Duk da haka, watanni shida bayan dasawa, cutar sankarar jini ta sake dawowa, kuma ba a sake samun ƙarin maganin chemotherapy ba. Iyalin sun nemi wasu magunguna amma suna fuskantar ƙuntatawa a Siriya, inda ba a sami magunguna na zamani kamar CAR-T ba.

Bayan bincike mai zurfi, Mohammed ya gano cewa kasar Sin ce kan gaba a fannin maganin CAR-T kuma asibitin ya yi wa marasa lafiya sama da 500 magani tare da samun nasara sosai, musamman ga DUKKAN mutane, inda ya nuna cewa adadin ya warke sama da kashi 90%. Da yake samun kwarin gwiwa daga wadannan kididdiga, Mohammed ya shirya wa mahaifiyarsa ta sami magani a Asibitin Lu Daopei.

Da isowarta kasar Sin, likitoci sun gano cewa majiyyaciyar tana da babban nauyin ciwon daji na kashi 80% a cikin kasusuwanta, wanda hakan ya sanya ta a matsayin majiyyaciyar da ke cikin hatsarin kamuwa da cutar. Duk da wadannan kalubalen, tawagar likitoci a asibiti, Dr. Song ta fara magani ta amfani da kwayoyin CAR-T da BIOOCUS ke bayarwa, wanda ya kware wajen isar da kayayyakin CAR-T na zamani zuwa asibitoci a duk duniya.

Bayan kwanaki 15 kacal na maganin CAR-T, tare da maganin chemotherapy, majiyyaciyar ta sami cikakkiyar sassauci. Sakamakon gwajinta ya nuna cewa MRD ba shi da alaƙa da cutar sankarar bargo, ma'ana babu ƙwayoyin cutar sankarar bargo da za a iya ganowa. Mohammed ya nuna matuƙar godiya ga sakamakon, yana mai cewa, "Abin al'ajabi ne. Maganin chemotherapy ko wani maganin rigakafi ba zai haifar da irin wannan sakamako ba. Maganin CAR-T ya ceci rayuwar mahaifiyata."

Ya kuma yaba wa tawagar BIOOCUS Medical group yana mai cewa, "Likitoci da ma'aikatan, musamman waɗanda ke Cibiyar Ƙasa da Ƙasa, sun kasance ƙwararru kuma masu kulawa sosai. Ba wai kawai sun ba da kulawar lafiya mafi girma ba, har ma da tallafin motsin rai a duk lokacin wannan ƙalubalen."

Wannan shari'ar ta nuna ƙarfin maganin CAR-T wajen magance DUKKAN marasa lafiya masu haɗarin kamuwa da cutar, musamman waɗanda magungunan gargajiya suka gaza a gare su. Tare da BIOOCUS a matsayin abokin tarayya mai aminci wajen samar da kayayyakin CAR-T na zamani, asibitin yana ci gaba da jagorantar samar da magungunan ceton rai da kuma ci gaba da maganin cutar kansa.

Ga marasa lafiya da ke fama da DUKA, maganin CAR-T yana ba da sabon bege, koda a cikin mawuyacin hali. Asibitin Lu Daopei ya ci gaba da jajircewa wajen samar da sabbin magunguna da inganta sakamakon ga marasa lafiya da ke fama da cutar kansar jini.